A randomised controlled trial of triple antiplatelet therapy (aspirin, clopidogrel and dipyridamole) in the secondary prevention of stroke: safety, tolerability and feasibility.

Source:http://linkedlifedata.com/resource/pubmed/id/18682741

Download in:

View as

General Info

PMID
18682741